Company Filing History:
Years Active: 1997-1999
Title: Frank Friedlos: Innovator in Cancer Research
Introduction
Frank Friedlos is a notable inventor based in Sutton, GB. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 3 patents, Friedlos has focused on developing prodrugs that enhance the efficacy of cancer treatments.
Latest Patents
Friedlos's latest patents include groundbreaking work on bacterial nitroreductase for the reduction of CB1954 and its analogues. One of his notable inventions is a prodrug of the formula (I), where R.sup.1 is a group such that the compound R.sup.1 NH.sub.2 represents actinomycin D, doxorubicin, mitomycin C, or a nitrogen mustard of the formula (IV). Additionally, he has developed a prodrug of the formula (II), where R.sup.2 is a group such that the compound R.sup.2 OH is a phenolic nitrogen mustard. His processes involve reacting a prodrug precursor compound with 4-nitrobenzyl chloroformate under anhydrous conditions.
Career Highlights
Friedlos is currently associated with Cancer Research Campaign Technology Limited, where he continues to push the boundaries of cancer treatment through his innovative research. His work has been instrumental in advancing the understanding and application of prodrugs in oncology.
Collaborations
Friedlos has collaborated with esteemed colleagues such as Gillian Anlezark and Roger Melton. Their combined expertise has contributed to the success of various projects aimed at improving cancer therapies.
Conclusion
Frank Friedlos stands out as a dedicated inventor in the realm of cancer research. His innovative patents and collaborations reflect his commitment to enhancing treatment options for patients.